Global Breath Molecular Diagnostic Device Market Growth 2024-2030
The global Breath Molecular Diagnostic Device market size is projected to grow from US$ 257 million in 2024 to US$ 520 million in 2030; it is expected to grow at a CAGR of 12.4% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Breath Molecular Diagnostic Device Industry Forecast” looks at past sales and reviews total world Breath Molecular Diagnostic Device sales in 2023, providing a comprehensive analysis by region and market sector of projected Breath Molecular Diagnostic Device sales for 2024 through 2030. With Breath Molecular Diagnostic Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breath Molecular Diagnostic Device industry.
This Insight Report provides a comprehensive analysis of the global Breath Molecular Diagnostic Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breath Molecular Diagnostic Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breath Molecular Diagnostic Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breath Molecular Diagnostic Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breath Molecular Diagnostic Device.
United States market for Breath Molecular Diagnostic Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Breath Molecular Diagnostic Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Breath Molecular Diagnostic Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Breath Molecular Diagnostic Device players cover NIOX Group plc, Headway, Sunvou Medical Electronics Co, CAIRE (NGK), Richen Holding, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Breath Molecular Diagnostic Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
C13 Type
NO Type
H2/CO Type
VOCs Type
Segmentation by Application:
Hospital
Clinic
Physical Examination Center
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
NIOX Group plc
Headway
Sunvou Medical Electronics Co
CAIRE (NGK)
Richen Holding
Meridian Bioscience
CAPNIA, Inc.
Kibion
Otsuka Electronics
LEYI BIOLOGY
Eco Physics AG
Shenzhen Breax
QUINTRON
Beijing Wanliandaxinke Instruments Co
SIMES SIKMA
Beijing Safe Heart Technology
e-LinkCare Meditech Co
ChromX Health
Huiyuen Tech
Owlstone Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Breath Molecular Diagnostic Device market?
What factors are driving Breath Molecular Diagnostic Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Breath Molecular Diagnostic Device market opportunities vary by end market size?
How does Breath Molecular Diagnostic Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.